Taysha Gene Therapies, Inc. (TSHA) Revenue Growth
Taysha Gene Therapies, Inc. (TSHA) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2021-12-31 | N/A |
| 2022-12-31 | N/A |
| 2023-12-31 | 517.55% |
| 2024-12-31 | -46.07% |
| 2025-12-31 | 17.28% |
How TSHA compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| SPRO | Spero Therapeutics Inc. | 39.24% |
| IONS | Ionis Pharmaceuticals Inc. | 33.83% |
| NTLA | Intellia Therapeutics Inc. | 16.92% |
| VERU | Veru Inc. | 3.62% |
| BNTC | Benitec Biopharma Inc. | 2.74% |
These are five companies in the same sector as TSHA with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Taysha Gene Therapies, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("TSHA", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TSHA | $5.70 | +0.18% | 1.76M |
| 3 | ||||
| 4 | ||||
| 5 |